Interestingly, C-end rule peptides with a C-terminal arginine residue in a configuration similar to that of VEGF-A bind NRP1 to induce vascular permeability [83], and this property may be exploited to enhance tumor penetration of chemotherapeutic drugs [2]. This evidence concerns the gene NRP1 and neoplasm.